First Trust Advisors
UROV

First Trust Advisors’s Urovant Sciences Ltd. UROV Stock Holding History

First Trust Advisors’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,299
Closed -$151K – 2546
2020
Q2 		$151K Buy
15,299
+1,144
+8% +$11K ﹤0.01% 2299
2020
Q1 		$131K Sell
14,155
-2,744
-16% -$33K ﹤0.01% 2276
2019
Q4 		$262K Sell
16,899
-308
-2% -$3.34K ﹤0.01% 2303
2019
Q3 		$163K Buy
+17,207
New +$149K ﹤0.01% 2350

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors's UROV Position: Q3 2020 in Review

First Trust Advisors sold out of Urovant Sciences Ltd. (UROV) in Q3 2020, closing a stake of 15,299 shares — an estimated $151K sold.

First Trust Advisors first reported a position in UROV in Q3 2019 and held it in 4 quarters. The position peaked at $262K in Q4 2019. 23 funds tracked by Wall St. Rank hold UROV as of Q3 2020.

  • First Trust Advisors reported no remaining Urovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • First Trust Advisors sold 15,299 Urovant Sciences Ltd. shares in Q3 2020, an estimated $151K.
  • First Trust Advisors first reported a position in Urovant Sciences Ltd. in Q3 2019 and held it in 4 quarters.
  • First Trust Advisors's Urovant Sciences Ltd. position peaked at $262K in Q4 2019.
  • 23 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q3 2020.

Based on First Trust Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.